Padcev User Reviews & Ratings
Padcev has an average rating of 1.0 out of 10 from a total of 2 reviews on Drugs.com. 0% of reviewers reported a positive experience, while 100% reported a negative experience.
Condition | Avg. Rating | Reviews | Compare |
---|---|---|---|
Urothelial Carcinoma | 2 reviews for Urothelial Carcinoma | 7 medications |
- DMa...
- April 16, 2021
For Urothelial Carcinoma "My son was diagnosed with Stage 4 bladder cancer in Oct/2019. His treatment consisted of surgery, radiation, chemotherapy, Keytruda, before being treated with Padcev. The side effects from his first dose of Padcev were much like his previous treatment of chemotherapy back in Dec/2019-Feb/2020. He was tired, nauseous, and lost his appetite. After his second dose, he immediately lost his hair, he was nauseous, lost his appetite, and had diarrhea. But the most frightening side effect was he developed a rash that was ugly, red, and blistery. A week later, based on the results of a blood test, he was called and told to go to the ER for what we thought was either iron or a blood transfusion, but after getting there, the ER doctor told us that he was in renal failure and would have to stay in the hospital until they found the cause of it and were able to treat it. They were never able to get his kidneys working again. He ended up passing away 5 days after he was admitted to the hospital."
Are you taking this medicine?
Your review helps others make informed decisions.More about Padcev (enfortumab vedotin)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
For Urothelial Carcinoma "Severe reaction to the medication Padcev. Suffering blisters all over my body that bleed profusely. No one has answered questions about how long the medication remains in the system after discontinued."